Retraction Note: Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway

Retraction Note: Stem Cell Research & Therapy (2018) 9:57 10.1186/s13287-018-0771-y

The Editors-in-Chief have retracted this article at the authors' request. After publication, the authors found errors in the following figure panels:

• Fig. 2a: The representative ALP staining images of 15 and 30 μM are both chosen from the 30 μM group

• Figs. 4d, 5h and 5i: The same β-actin blot is used.

• Fig. 4e and f: The same β-actin blot is used

• Fig. 5a: The representative ALP staining images of Azo+si-glp-1r-1 and Azo+si-glp-1r-2 are the same

The authors provided the raw data for validation. However, further checks by the Publisher identified some differences between the raw data and the figures, as well as high similarity between the original gel images for Fig. 5b GLP-1 and 5i Fabp4. The Editors-in-Chief and the authors therefore no longer have confidence in the presented data.

All authors agree to this retraction.